SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?


To: brad greene who wrote (13345)5/3/1999 6:01:00 PM
From: David  Read Replies (1) | Respond to of 26039
 
Credit Yahoo with this link:

wallstreetreporter.com.

A long interview with Otis Bradley (Gilford Securities) from April 14, pumping IDX. I mean, really pumping it.

He's full of Intel/MSFT references. Says the stock should "double" after the merger is announced . . . in context, that means $15. Although he doesn't directly say it, it sounds like he knows that H-P is picking IDT, and that sales are being made to Coca-Cola, Ford and Aetna. (I remember Fowler mentioning Ford, too.)

Bradley thinks fingerscanners will be universal in 2-4 years on PCs, i.e., shipped at the rate of 100 million a year . . . and IDX could have an 80% market share. Retail price of $30-$50 by then.

He mentions an API fight earlier this year between BioAPI and an Intel alliance, which BioAPI won. He then concludes that having Identicator on the winning side is like "the fox guarding the chicken coop" since IDT will be the only maker that will be able to meet the API standards.

There's more. Listen for yourself. Brad, I think you are conservative on this stock compared to this guy.